Patents

Title

Publication number

Applicant*

1,2,4-triazole derivatives as tankyrase inhibitors

WO 2019243822 A1

Oslo Univ Hospital, FVB, Univ Oulo

Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors

WO 2019234237 A1

FVB

Polyproline mimetics of proline-derived module-15

WO 2019162524 A1

FVB, Univ zu Köln

Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways

CA 3041832 A1, AU 2017359276 A1, US 2019276452 A1, EP 3538529 A1, JP 2019535709 A, CN 109963850 A

MDC, FVB

Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates

WO 2019170710 A3

FVB, LMU

Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

US 2019330264 A1, CA 3032251 A1, AU 2017320913 A1, CN 109689112 A, JP 2019532041 A, EP 3506949 A1

FVB, LMU

Molecular sensor for NMR/MRI based on analyte-dependent spectral changes of temporarily encapsulated hyperpolarized 129Xe

EP 3491389 A1, US 2019307907 A1

TUM, FVB

Unusual substrates of tubulin tyrosine ligase

AU 2017255938 A1, US 2019144493 A1, EP 3448870 A1, CA 3021526 A1

FVB, LMU

Antagonists of the thyroid-stimulating hormone receptor (TSHR)

EP 3448381 A1, US 2019134024 A1

FVB

Means and methods for site-specific functionalization of polypeptides

US 10208084 B2, US 2019337977 A1, EP 3212659 A1, CA 2964837 A1, AU 2015340591 A1

LMU, FVB

Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same

US 10214530 B2, EP 3262044 B1, US 2019161503 A1, EP 3490996 A1

FVB, MDC

Inhibitors for inhibiting tumor metastasis

US 10344053 B2, EP 3230300 A1

FVB, Univ zu Köln

LRRC8 proteins and protein complexes and methods for identification of channel modulators

US 9927423 B2, EP 2919009 B1

FVB, MDC

Structural mimetics of proline-rich peptides and use thereof

US 9242985 B2, JP 2017165761 A, EP 2747764 B1

FVB, Univ zu Köln

Induction of alpha helix conformations in proteins and peptides

US 8815932 B2, EP 2451815 B1

Univ zu Köln, FVB

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

US 8741259 B2, US 9187457 B2, US 9296729 B2, US 9458141 B2, JP 5718233 B2, JP 2012506841 A, EP 2358684 B8, AU 2008363295 B2, AU 2015204281 B2, AU 2016204845 B2

US Health, FVB

Structural mimetics of proline-rich peptides and the pharmaceutical use thereof

US 8242105 B2, JP 5588172 B2, EP 2094711 B8

FVB

*FVB - Forschungsverbund Berlin e.V. (for its Leibniz-Forschungsinstitut für Molekulare Pharmakologie); LMU - Ludwig-Maximilians-Universität München; MDC - Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft; Oslo Univ Hospital - Oslo University Hospital HF; TUM - Technische Universität München; Univ Oulo - University of Oulo; Univ zu Köln - Universität zu Köln; US Health - The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)
info(at)fmp-berlin.de

Like many sites, we use cookies to optimize the user's browsing experience. Data Protection OK